Nokin P, Clinet M, Swillens S, Delisée C, Meysmans L, Chatelain P
J Cardiovasc Pharmacol. 1986 Sep-Oct;8(5):1051-7. doi: 10.1097/00005344-198609000-00025.
The possible interaction between the antianginal and antiarrhythmic drug amiodarone and the slow calcium channel was investigated by competition binding experiments in guinea-pig cerebral cortex and rat heart membranes using [3H]nitrendipine as radioligand. Amiodarone displaced specifically bound [3H]nitrendipine from cerebral cortex and cardiac membranes in an apparently competitive manner. In saturation binding experiments, apparent affinity for [3H]nitrendipine progressively decreased with increasing concentrations of amiodarone, whereas maximal binding capacity (Bmax remained unchanged. Both diltiazem and verapamil reversed the inhibitory effect of amiodarone on [3H]nitrendipine binding to cerebral cortex membranes. Together these results suggest that amiodarone exerts a pseudocompetitive inhibition on [3H]nitrendipine binding by acting at a site in allosteric interaction with the 1,4 dihydropyridine binding site associated with the calcium channel. The data are compatible with the existence of a common binding site for diltiazem, verapamil, and amiodarone. These observations are discussed in connection with the pharmacological properties of the drug.
使用[3H]尼群地平作为放射性配体,通过豚鼠大脑皮层和大鼠心脏膜的竞争结合实验,研究了抗心绞痛和抗心律失常药物胺碘酮与慢钙通道之间可能的相互作用。胺碘酮以明显竞争的方式从大脑皮层和心脏膜中特异性置换结合的[3H]尼群地平。在饱和结合实验中,随着胺碘酮浓度的增加,对[3H]尼群地平的表观亲和力逐渐降低,而最大结合容量(Bmax)保持不变。地尔硫卓和维拉帕米均可逆转胺碘酮对[3H]尼群地平与大脑皮层膜结合的抑制作用。这些结果共同表明,胺碘酮通过作用于与钙通道相关的1,4 - 二氢吡啶结合位点进行变构相互作用的位点,对[3H]尼群地平结合产生假竞争性抑制。这些数据与地尔硫卓、维拉帕米和胺碘酮存在共同结合位点相符。结合该药物的药理特性对这些观察结果进行了讨论。